Hypertrust Patient Data Care (HPDC) has launched its extended Hypertrust X-Chain supply chain management solution for Advanced & Personalized Therapies (APT). The company states that it is the first solution that allows biotech and pharmaceutical companies to design, set up, plan, orchestrate, operate and scale APT supply chains with one single system.
The new applications added to Hypertrust X-Chain are:
Hypertrust X-Chain can be implemented as an all-in-one supply chain management solution or flexibly with a focus on specific modules to complement existing system landscapes.
HPDC adds that different modules of Hypertrust X-Chain are combinable, configurable, and scalable to manage end-to-end supply chain needs across all therapy life cycle phases, from the clinical phase up to post-commercialization.
Click to enlarge.
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Study Connects COVID-19 Treatment Disparities to Gaps in Testing and Virtual Access
July 11th 2025New research finds that nearly half of the racial and ethnic disparities in outpatient COVID-19 antiviral prescriptions stem from encounter-level care barriers, such as limited access to rapid tests and telehealth, which emphasizes the need for systemic and practice-level reforms.